AUG 15, 2026 · JOURNAL ARTICLE
Therapeutic potential and underlying mechanisms of engineered young plasma-derived exosomes in Alzheimer's disease.
Bioactive Materials
This is a preclinical mechanistic study in transgenic AD mouse models using engineered exosomes; it demonstrates a proposed therapeutic pathway but lacks clinical translation, human data, or rigorous comparison to establish practice-changing or even strong evidence.
Study details
DesignPreclinical mechanistic study in transgenic…
InterventionRVG-engineered young plasma-derived exosome…
ComparatorYoung plasma-derived exosomes (unengineered…